IRF2, and MxA, has been seen.11 According to the low level of IFNβ, protein products of these genes are low in MS patients in comparison to healthy individuals.15 A significantly reduced level of IRF1 mRNA is reported in MS patients. This evidence concerns the gene IFNB1 and myeloid sarcoma.